iLB-281bfs191, PH-BL-402 Clone 191

The cell line is not validated yet.

General

Cell Line

hPSCreg name LBi014-A
Cite as:
LBi014-A (RRID:CVCL_C6R7)
Alternative name(s)
iLB-281bfs191, PH-BL-402 Clone 191
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
LBi014-B
(PH-BL-402 Clone 192, iLB-281bfs192)
Donor diseases:
Alzheimer disease
STBCi006-A-1
(ApoE KO)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
STBCi006-A-3
(ApoE 3/3)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
STBCi006-A-4
(ApoE 3/4)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UMi042-A-1
(408737 CB9)
Donor diseases:
Alzheimer's Disease
UKBi011-A-1
(iLB-AD + ApoE KO)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKBi011-A-2
(ApoE 2/2)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKBi011-A-3
(ApoE 3/3)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKBi011-A-4
(ApoE 3/4)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
LBi001-A
(PH-BL-001 Clone 4, iLB-268bfs4)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi001-B
(iLB-268bfs9, PH-BL-001 Clone 9)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi002-A
(PH-BL-002 Clone 2, iLB-272bfs2)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi002-B
(PH-BL-002 Clone 9, iLB-272bfs9)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi004-A
(PH-BL-204 Clone 210, iLB-278bfs210)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi004-B
(PH-BL-204 Clone 211, iLB-278bfs211)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi011-A
(PH-BL-004 Clone 14, iLB-274bfs14)
Donor diseases:
Alzheimer disease
LBi011-B
(PH-BL-004 Clone 17, iLB-274bfs17)
Donor diseases:
Alzheimer disease
LBi013-A
(PH-BL-304 Clone 117, iLB-279bfs117)
Donor diseases:
Alzheimer disease
LBi016-A
(PH-BL-414 Clone 10, iLB-296bfs10)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi016-B
(PH-BL-414 Clone 16, iLB-296bfs16)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi017-A
(PH-BL-401 Clone 22, iLB-280bfs22)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi017-B
(PH-BL-401 Clone 36, iLB-280bfs36)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi018-A
(PH-BL-409 Clone 43, iLB-291bfs43)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi018-B
(PH-BL-409 Clone 45, iLB-291bfs45)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi003-A
(iLB-273bms57, PH-BL-003 Clone 57)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi003-B
(PH-BL-003 Clone 61, iLB-273bms61)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi005-A
(iLB-293bms257, PH-BL-411 Clone 257)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi005-B
(iLB-293bms258, PH-BL-411 Clone 258)
Donor's gene variants:
CD33, CD33, CD33, CD33
Donor diseases:
Alzheimer disease
LBi012-A
(iLB-292bms74, PH-BL-410 Clone 74)
Donor diseases:
Alzheimer disease
LBi012-B
(PH-BL-410 Clone 80, iLB-292bms80)
Donor diseases:
Alzheimer disease
LBi015-A
(iLB-277bms227, PH-BL-303 Clone 227)
Donor diseases:
Alzheimer disease
LBi015-B
(iLB-277bms234, PH-BL-303 Clone 234)
Donor diseases:
Alzheimer disease
LBi019-A
(PH-BL-901 Clone 154, iLB-275bms154)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi019-B
(iLB-275bms162, PH-BL-901 Clone 162)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
LBi020-A
(iLB-294bms22, PH-BL-412 Clone 238)
Donor's gene variants:
TREM2, TREM2
Donor diseases:
Alzheimer disease
BIOTi001-A
(BIOT-7183-PSEN1)
Donor's gene variants:
PSEN1
Donor diseases:
obsolete_Alzheimer's disease
ZZUi010-A
(ZZU-iPS-AD-APP-001)
Donor diseases:
obsolete_Alzheimer's disease
MUNIi021-A
(sAD5)
Donor diseases:
Alzheimer's Disease
Last update 1st March 2023
Notes CD33 high risk Alzheimer disease TREM2-/- CD33+/+ (TREM2WT/WT, CD33M/M)
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Life & Brain GmbH (LB)
Distributors
Derivation country Germany

External Databases

BioSamples SAMEA111521230
Cellosaurus CVCL_C6R7
Wikidata Q117704619

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 70-74
Ethnicity White European

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
TREM2WT/WT CD33 full length variant /full length variant
The donor is not a carrier of a disease-associated mutation and not affected.
Stage
Cognitively normal on the day of sample donation
Synonyms
  • Late-onset form of familial Alzheimer disease
  • Alzheimer disease
Disease associated phenotypes no phenotypes

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA111522584

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink angela.k.hodges@kcl.ac.uk
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? Yes
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? Yes
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Health Research Authority
Approval number 224771
Do you have obligations to third parties in regard to the use of the cell line? Yes
Please describe: EMDA and L&B
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
Committed, erythroid stem cells derived from myeloid stem cells. The progenitor cells develop in two phases: erythroid burst-forming units (bfu-e) followed by erythroid colony-forming units (cfu-e). Bfu-e differentiate into cfu-e on stimulation by erythropoietin, and then further differentiate into erythroblasts when stimulated by other factors.
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
Synonyms
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
  • BLOOD
  • portion of blood
  • vertebrate blood
show more synonyms
Age of donor (at collection) 70-74
Collected in 2018

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzymatically
Accutase
O2 Concentration 20 %
CO2 Concentration 6 %
Medium Other medium:
Base medium: StemMACS™ iPS-Brew XF, Basal Medium
Main protein source: StemMACS™ iPS Brew XF, 50x Supplement
Serum concentration: %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Morphology pictures

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage:

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal 46XX
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Cell Line)